From October 2023 to March 2024, a total of (50) clinical specimens were taken from infected pregnant women. The women visited AL-Sadder Medical City and AL-Zahra General Hospital during the study time and provided these specimens.  All samples were tested with the TORCH test and the results were recorded. Among a sample of 50 patients, an equal number of 25 (50%) were identified as IgM positive for Rubella virus and IgG positive for Herpes Simplex -1 viruses, while 25 (50%) as IgG positive for Herpes Simplex -1 viruses with a negative result for Rubella virus.

   The findings of the study indicate that 25 of the women with IgM positive for Rubella virus and IgG positive for Herpes Simplex-1 viruses are more susceptible to preeclampsia and miscarriage, whereas the 25 women with IgG positive for Herpes Simplex -1 viruses with negative results for Rubella virus are healthier pregnancy without any symptoms of miscarriage or preeclampsia.